Get started
Author

Masahiro Kojima

Interim Analysis of a Phase 2 Open-Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor-Induced Osteomalacia
2020 · Yasuo Imanishi, Nobuaki Ito, et al. · Journal of Bone and Mineral Research · 100
PDF
Randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease: design and baseline characteristics of the AYAME study
2022 · Masaomi Nangaku, Hirotaka Takama, et al. · Nephrology Dialysis Transplantation · 55
PDF
Safety and Efficacy of Burosumab in Pediatric Patients With X-Linked Hypophosphatemia: A Phase 3/4 Open-Label Trial
2022 · Noriyuki Namba, Takuo Kubota, et al. · Journal of the Endocrine Society · 21
Early completion of phase I cancer clinical trials with Bayesian optimal interval design
2021 · Masahiro Kojima · Statistics in Medicine · 12
Application of multi-armed bandits to dose-finding clinical designs
2023 · Masahiro Kojima · Artificial Intelligence in Medicine · 10
PDF
Comparison of the Oral Calcimimetics Evocalcet and Cinacalcet in East Asian Patients on Hemodialysis with Secondary Hyperparathyroidism
2023 · Zhaohui Ni, Xinling Liang, et al. · Kidney International Reports · 8
PDF
Early Completion of Model-Assisted Designs for Dose-Finding Trials
2021 · Masahiro Kojima · JCO Precision Oncology · 7
Variable selection using inverse probability of censoring weighting
2023 · Masahiro Kojima · Statistical Methods in Medical Research · 5
PDF
Adaptive design for identifying maximum tolerated dose early to accelerate dose-finding trial
2022 · Masahiro Kojima · BMC Medical Research Methodology · 5
PDF
Bartlett-type adjustments for hypothesis testing in linear models with general error covariance matrices
2013 · Masahiro Kojima, Tatsuya Kubokawa · Journal of Multivariate Analysis · 5
PDF
DBMS: dynamic borrowing method for frequentist hybrid control designs based on historical-current data similarity
2025 · Masahiro Kojima · The International Journal of Biostatistics · 4
PDF
Pharmacokinetics, Pharmacodynamics, and Safety of Evocalcet (KHK7580), a Novel Calcimimetic Agent: An Open-Label, Single- and Multiple-Dose, Phase I Trial in Healthy Chinese Subjects
2024 · Xuemei He, Kazuya Narushima, et al. · Drug Design Development and Therapy · 3
PDF
Adjusted closed‐form confidence interval formulas for network meta‐analysis with a small number of studies
2022 · Masahiro Kojima · Statistics in Medicine · 2
PDF
ORCHESTRA Trial: Head-to-Head Comparison of Oral Calcimimetics Evocalcet and Cinacalcet in East Asian Hemodialysis Patients With Secondary Hyperparathyroidism
2022 · Xinling Liang, Zhaohui Ni, et al. · Journal of the American Society of Nephrology · 2
Early completion based on multiple dosages to accelerate maximum tolerated dose-finding
2021 · Kojima, Masahiro · arXiv (Cornell University) · 2
PDF
Code for Prediction-Risk Propagation and Model-Comparison Feedback in Q-Learning for Sequential Multiple Assignment Randomised Trials
2026 · Kojima, Masahiro · Zenodo (CERN European Organization for Nuclear Research) · 1
Sample Size Re‐Estimation in Blinded Hybrid‐Control Design Using Inverse Probability Weighting
2026 · Masahiro Kojima, Shunichiro Orihara, et al. · Statistics in Medicine · 1
PDF
Multi-armed bandits backfill Bayesian optimal interval design
2025 · Masahiro Kojima, Kentaro Takeda · Journal of Biopharmaceutical Statistics · 1
Data-dependent contrast test for dose-finding clinical trials
2023 · Masahiro Kojima · Contemporary Clinical Trials · 1
A Trajectory-Informed Clustering Approach for Information Borrowing in Basket Trials: Software
2026 · Kojima, Masahiro, Hanada, Keisuke, et al. · Zenodo (CERN European Organization for Nuclear Research)
Integrating Meta‐Analysis Into a Specific Study (InMASS) for Estimating the Target‐Population Average Treatment Effect
2026 · Keisuke Hanada, Masahiro Kojima · Biometrical Journal
PDF
Hybrid Non‐Informative and Informative Prior Model‐Assisted Designs for Mid‐Trial Dose Insertion
2026 · Masahiro Kojima, Kana Yamada, et al. · Statistics in Medicine
PDF
Finite-Boundary Reduction and Exact Verification of Strong Familywise Error in Active-Count-Coupled Multi-Arm Efficacy--Toxicity Monitoring
2026 · Kojima, Masahiro, Sunami, Hisato, et al. · arXiv (Cornell University)
PDF
Seamless Phase I– II Cancer Clinical Trials Using Kernel‐Based Covariate Similarity
2026 · Kana Makino, Natsumi Makigusa, et al. · Pharmaceutical Statistics
PDF
Simulation Results for "Integrating Meta-analysis into a Specific Study (InMASS) for Estimating the Target-Population Average Treatment Effect"
2026 · Hanada, Keisuke, Kojima, Masahiro · Zenodo (CERN European Organization for Nuclear Research)
Works count: 34
Citation count: 245
H-index: 7
I10-index: 5
Year
Topic
Type